Cargando…
Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures
Over one million fractures occur per year in the US and are associated with impaired healing increasing patient morbidity, stress, and economic costs. Despite improvements in surgical technique, internal fixation, and understanding of biologics, fracture healing is delayed or impaired in up to 4% of...
Autores principales: | Ghodadra, Neil, Singh, Kern |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721393/ https://www.ncbi.nlm.nih.gov/pubmed/19707367 |
Ejemplares similares
-
Accelerators of Osteogenesis by Recombinant Human Bone Morphogenetic Protein-2
por: Okubo, Yasunori, et al.
Publicado: (2007) -
Use and efficacy of bone morphogenetic proteins in fracture healing
por: Lissenberg-Thunnissen, Suzanne N., et al.
Publicado: (2011) -
The concern on clinical use of recombinant human bone morphogenetic protein-2
por: Wiwanitkit, Viroj
Publicado: (2011) -
Use of recombinant human bone morphogenetic protein-2 in spine surgery
por: Lykissas, Marios, et al.
Publicado: (2017) -
Bone regenerative effect of recombinant human bone morphogenetic protein-2 after cyst enucleation
por: Hwang, Doo Yeon, et al.
Publicado: (2016)